These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35799892)

  • 1. LINC00092 Modulates Oxidative Stress and Glycolysis of Breast Cancer Cells via Pyruvate Carboxylase-Mediated AKT/mTOR Pathway.
    Chen W; Liu Y; Kang S; Lv X; Fu W; Zhang J; Song C
    Oxid Med Cell Longev; 2022; 2022():5215748. PubMed ID: 35799892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction.
    Jia L; Huang S; Yin X; Zan Y; Guo Y; Han L
    Life Sci; 2018 Sep; 208():123-130. PubMed ID: 30025823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RBM8A Depletion Decreases the Cisplatin Resistance and Represses the Proliferation and Metastasis of Breast Cancer Cells via AKT/mTOR Pathway.
    Song T; Zhang H
    Breast J; 2022; 2022():4576789. PubMed ID: 36105365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/Akt/mTOR signaling pathway.
    Bi QJ; Men XJ; Han R; Li GL
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3067-3073. PubMed ID: 29863252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBXIP accelerates glycolysis and promotes cancer angiogenesis via AKT/mTOR pathway in bladder cancer.
    Liu X; Li H; Che N; Zheng Y; Fan W; Li M; Li X; Xuan Y
    Exp Mol Pathol; 2021 Aug; 121():104665. PubMed ID: 34216584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPOCK1/SIX1axis promotes breast cancer progression by activating AKT/mTOR signaling.
    Xu M; Zhang X; Zhang S; Piao J; Yang Y; Wang X; Lin Z
    Aging (Albany NY); 2020 Dec; 13(1):1032-1050. PubMed ID: 33293473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway.
    Lu PW; Li L; Wang F; Gu YT
    J Cell Physiol; 2019 Feb; 234(2):1904-1912. PubMed ID: 30145819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR-glycolysis signaling axis.
    Li R; Weng L; Liu B; Zhu L; Zhang X; Tian G; Hu L; Li Q; Jiang S; Shang M
    J Cell Biochem; 2020 Feb; 121(2):1986-1997. PubMed ID: 31693252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway.
    Li Z; Li C; Wu Q; Tu Y; Wang C; Yu X; Li B; Wang Z; Sun S; Sun S
    Cell Death Dis; 2021 Jan; 12(1):97. PubMed ID: 33462219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: LINC00092 Modulates Oxidative Stress and Glycolysis of Breast Cancer Cells via Pyruvate Carboxylase-Mediated AKT/mTOR Pathway.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9864513. PubMed ID: 38189021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC00941 promoted in vitro progression and glycolysis of laryngocarcinoma by upregulating PKM via activating the PI3K/AKT/mTOR signaling pathway.
    Li Z; Jin Q; Sun Y
    J Clin Lab Anal; 2022 Jul; 36(7):e24406. PubMed ID: 35588431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZNF488 Promotes the Invasion and Migration of Pancreatic Carcinoma Cells through the Akt/mTOR Pathway.
    Qiu H; Zhang L; Wang D; Zhang Y; Cai H; Miao H; Chu F
    Comput Math Methods Med; 2022; 2022():4622877. PubMed ID: 35111235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nesfatin-1 Promotes Proliferation, Migration and Invasion of HTR-8/SVneo Trophoblast Cells and Inhibits Oxidative Stress via Activation of PI3K/AKT/mTOR and AKT/GSK3β Pathway.
    Li T; Wei S; Fan C; Tang D; Luo D
    Reprod Sci; 2021 Feb; 28(2):550-561. PubMed ID: 32974855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cancer-testis antigen a-kinase anchor protein 3 facilitates breast cancer progression via activation of the PTEN/PI3K/AKT/mTOR signaling.
    Zhan CH; Ding DS; Zhang W; Wang HL; Mao ZY; Liu GJ
    Bioengineered; 2022 Apr; 13(4):8478-8489. PubMed ID: 35322748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of cannabinoid receptor 2 is associated with human breast cancer proliferation, apoptosis, chemosensitivity and prognosis via the PI3K/Akt/mTOR signaling pathway.
    Song Q; Zhang W; Shi D; Zhang Z; Zhao Q; Wang M; Huang M; Meng J; Cui W; Luo X
    Cancer Med; 2023 Jun; 12(12):13538-13550. PubMed ID: 37220224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC00960 regulates cell proliferation and glycolysis in pancreatic cancer through the miR-326-3p/TUFT1/AKT-mTOR axis.
    Zhou B; Lei JH; Wang Q; Qu TF; Cha LC; Zhan HX; Liu SL; Hu X; Sun CD; Cao JY; Qiu FB; Guo WD
    Kaohsiung J Med Sci; 2022 Dec; 38(12):1155-1167. PubMed ID: 36149758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CKAP2L, transcriptionally inhibited by FOXP3, promotes breast carcinogenesis through the AKT/mTOR pathway.
    Chi F; Chen L; Jin X; He G; Liu Z; Han S
    Exp Cell Res; 2022 Mar; 412(2):113035. PubMed ID: 35065924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancer.
    Shinde A; Wilmanski T; Chen H; Teegarden D; Wendt MK
    Breast Cancer Res; 2018 Jul; 20(1):76. PubMed ID: 30005601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N6-methyladenosine-mediated upregulation of LINC00520 accelerates breast cancer progression via regulating miR-577/POSTN axis and downstream ILK/AKT/mTOR signaling pathway.
    Guo Y; Feng L
    Arch Biochem Biophys; 2022 Oct; 729():109381. PubMed ID: 36027936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YBX1/lncRNA SBF2-AS1 interaction regulates proliferation and tamoxifen sensitivity via PI3K/AKT/MTOR signaling in breast cancer cells.
    Hussain SA; Venkatesh T
    Mol Biol Rep; 2023 Apr; 50(4):3413-3428. PubMed ID: 36754932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.